Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges

被引:8
|
作者
Ceresoli, Giovanni Luca [1 ]
Bonomi, Maria [1 ]
Sauta, Maria Grazia [1 ]
机构
[1] Clin Humanitas Gavazzeni, Thorac & GU Oncol Unit, Dept Med Oncol, I-24125 Bergamo, Italy
关键词
Malignant pleural mesothelioma; immunotherapy; immune-checkpoint inhibitors; SINGLE-ARM; OPEN-LABEL; TREMELIMUMAB; CISPLATIN; BLOCKADE; PHASE-2; CANCER; SAFETY;
D O I
10.1080/14737140.2016.1191951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:673 / 675
页数:3
相关论文
共 50 条
  • [41] Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges
    Alfayez, Mansour
    Borthakur, Gautam
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (05) : 373 - 389
  • [42] In vitro analysis of cox inhibitors in malignant pleural mesothelioma
    O'Kane, S
    Cawkwell, L
    Lind, M
    LUNG CANCER, 2005, 49 : S388 - S388
  • [43] Imaging malignant pleural mesothelioma: Clinical applications and challenges
    Entwisle, J.
    LUNG CANCER, 2006, 54 : S19 - S19
  • [44] Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls
    Ceresoli, Giovanni Luca
    Ricardi, Umberto
    Vavassori, Vittorio
    Scorsetti, Marta
    RADIOTHERAPY AND ONCOLOGY, 2012, 105 (02) : 271 - 271
  • [45] Elucidation of tumor immune microenvironment of malignant pleural mesothelioma
    Yin Yuting
    ANNALS OF ONCOLOGY, 2022, 33 : S507 - S507
  • [46] Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
    Bograd, Adam J.
    Suzuki, Kei
    Vertes, Eva
    Colovos, Christos
    Morales, Eduardo A.
    Sadelain, Michel
    Adusumilli, Prasad S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (11) : 1509 - 1527
  • [47] Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesothelioma
    Okita, Riki
    Senoo, Tomoya
    Mimura-Kimura, Yuka
    Mimura, Yusuke
    Murakami, Tomoyuki
    Ikeda, Eiji
    Okada, Masanori
    Inokawa, Hidetoshi
    Aoe, Keisuke
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Characterization of the Genomic and Immune Landscape of Malignant Pleural Mesothelioma
    Bille, A.
    Torricelli, F.
    Ramsay, A. G.
    Ellis, R.
    Spada, F.
    Perov, N.
    Barberio, M. Terranovo
    Todd, K.
    Bishop, C.
    Nonaka, D.
    Apollonio, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S390 - S391
  • [49] Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
    Adam J. Bograd
    Kei Suzuki
    Eva Vertes
    Christos Colovos
    Eduardo A. Morales
    Michel Sadelain
    Prasad S. Adusumilli
    Cancer Immunology, Immunotherapy, 2011, 60 : 1509 - 1527
  • [50] Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma
    Minnema-Luiting, Jorien
    Vroman, Heleen
    Aerts, Joachim
    Cornelissen, Robin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)